Terug
Dagbereik
€ 11,71
€ 12,13
52-Weeksbereik
€ 6,69
€ 15,42
Volume
3.805.135
50D / 200D Gem.
€ 13,66
/
€ 10,91
Vorige Slotkoers
€ 11,92
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 52,7 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | 2,4 | 3,8 |
| Rev Growth 5Y % | 9,6 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 16,00
+32.6%
Low: € 15,00
High: € 17,00
Forward K/W
12,0
Forward WPA
€ 0,99
WPA Groei (sch.)
+0,0%
Omzet Sch.
3,1 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 1,37
€ 1,36 – € 1,39
|
3,5 B | 1 |
| FY2027 |
€ 1,18
€ 1,13 – € 1,24
|
3,3 B | 3 |
| FY2026 |
€ 0,99
€ 0,98 – € 1,00
|
3,1 B | 3 |
Belangrijkste Punten
Revenue grew 9,58% annually over 5 years — modest growth
Generating 269,93M in free cash flow
P/E of 52,70 — premium valuation
Cash machine — converts 374,60% of earnings into free cash flow
Capital efficient — spends only 2,32% of revenue on capex
Interest coverage of 1,75× — tight debt servicing
Groei
Revenue Growth (5Y)
9,58%
Revenue (1Y)8,05%
Earnings (1Y)N/A
FCF Growth (3Y)-1,18%
Kwaliteit
Return on Equity
N/A
ROIC11,90%
Net Margin2,39%
Op. Margin14,02%
Veiligheid
Debt / Equity
N/A
Current Ratio2,17
Interest Coverage1,75
Waardering
P/E Ratio
52,70
P/B RatioN/A
EV/EBITDA14,71
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,05% | Revenue Growth (3Y) | 12,30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9,58% | Earnings Growth (5Y) | 61,38% |
| Profitability | |||
| Revenue (TTM) | 3,02B | Net Income (TTM) | 72,06M |
| ROE | N/A | ROA | 1,96% |
| Gross Margin | 37,63% | Operating Margin | 14,02% |
| Net Margin | 2,39% | Free Cash Flow (TTM) | 269,93M |
| ROIC | 11,90% | FCF Growth (3Y) | -1,18% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,17 |
| Interest Coverage | 1,75 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 52,70 | P/B Ratio | N/A |
| P/S Ratio | 1,26 | PEG Ratio | -0,34 |
| EV/EBITDA | 14,71 | Dividend Yield | 0,00% |
| Market Cap | 3,80B | Enterprise Value | 6,22B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,02B | 2,79B | 2,39B | 2,21B | 2,09B |
| Net Income | 72,06M | -116,89M | -83,99M | -129,99M | 10,62M |
| EPS (Diluted) | 0,22 | -0,38 | -0,48 | -0,86 | 0,07 |
| Gross Profit | 1,14B | 1,02B | 863,87M | 791,46M | 768,97M |
| Operating Income | 423,09M | 249,33M | 204,37M | -94,93M | 152,72M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,68B | 3,50B | 3,47B | 3,80B | 3,94B |
| Total Liabilities | 3,67B | 3,55B | 3,41B | 3,59B | 3,57B |
| Shareholders' Equity | -70,79M | -109,27M | 19,78M | 298,42M | 360,34M |
| Total Debt | 2,74B | 2,59B | 2,75B | 2,85B | 2,88B |
| Cash & Equivalents | 310,87M | 110,55M | 91,54M | 25,98M | 247,79M |
| Current Assets | 1,91B | 1,59B | 1,38B | 1,41B | 1,52B |
| Current Liabilities | 881,63M | 1,13B | 846,60M | 752,80M | 677,24M |